Swallow Exercise as Prophylaxis of Dysphagia After Radiotherapy

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Kenneth Jensen, University of Aarhus
ClinicalTrials.gov Identifier:
NCT00332865
First received: June 1, 2006
Last updated: June 18, 2013
Last verified: June 2013
  Purpose

Background: Dysphagia is a common side effect after radiotherapy for haed and neck cancer patients. It may be worsened by immobility of the throat during tube feeding. Hypothesis: Exercises may prevent or reduce late dysphagia. Method: Phase I study to identify the tolerated intensity of exercises and establish the method of measuring training intensity and dysphagia measurement. Endpoint: Objective dysphagia using VF and FEESST. The HN swallowing and HN pain endpoint of EORTC H&N35 questionnaire. Weight loss, duration of tube feeding.


Condition Intervention Phase
Head and Neck Cancer
Behavioral: Swallowing Exercises
Phase 1
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Swallow Exercise as Prophylaxis of Dysphagia After Radiotherapy

Resource links provided by NLM:


Further study details as provided by University of Aarhus:

Primary Outcome Measures:
  • Objective swallowing using videofluoroscopy and endoscopic evaluation of swallowing [ Time Frame: 2 mths ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Weight [ Time Frame: 2 mths ] [ Designated as safety issue: No ]
  • Duration of tube feeding [ Time Frame: 2 mths ] [ Designated as safety issue: No ]
  • Swallowing scale of EORTC HN 35 [ Time Frame: 2 mths ] [ Designated as safety issue: No ]

Estimated Enrollment: 60
Study Start Date: June 2006
Study Completion Date: June 2013
Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: Swallowing Exercises
    Daily exercises
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Head and neck cancer
  • Planned curative radiotherapy
  • Planned irradiation of level II+III lymph nodes >46 Gy
  • >=18 y
  • Speaks and reads Danish
  • No previous Surgery to the head and neck area except biopsies

Exclusion Criteria:

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00332865

Locations
Denmark
Aarhus University Hospital
Aarhus, Denmark, 8000
Sponsors and Collaborators
University of Aarhus
Investigators
Principal Investigator: Kenneth Jensen, MD Aarhus University Hospital
  More Information

No publications provided

Responsible Party: Kenneth Jensen, MD ph.d., University of Aarhus
ClinicalTrials.gov Identifier: NCT00332865     History of Changes
Other Study ID Numbers: 20060059
Study First Received: June 1, 2006
Last Updated: June 18, 2013
Health Authority: Denmark: Danish Medicines Agency

Keywords provided by University of Aarhus:
Head and neck cancer
Radiotherapy
Dysphagia
Exercise
Deglutition
Randomized controlled trial
Quality of life
Tube feeding

Additional relevant MeSH terms:
Head and Neck Neoplasms
Neoplasms by Site
Neoplasms

ClinicalTrials.gov processed this record on September 16, 2014